COVID-19 and Acute Pancreatitis: Not Increased Risk but Reduced Care

被引:0
|
作者
Cevolani, Michele [1 ,2 ]
Ferronato, Marco [1 ,2 ]
Lizzio, Chiara Elide [1 ,2 ]
Elia, Eleonora [1 ,2 ]
Marini, Desy [1 ,2 ]
Mazzotta, Elena [1 ,2 ]
Ricci, Claudio [1 ,2 ]
Casadei, Riccardo [1 ,2 ]
机构
[1] Univ Bologna, Dept Internal Med & Surg DIMEC, Alma Mater Studiorum, Via Massarenti 9, I-40138 Bologna, Italy
[2] Univ Bologna, IRCCS Azienda Osped, Policlin St Orsola, Via Albertoni 15, I-40138 Bologna, Italy
关键词
acute pancreatitis; SARS-CoV-2; COVID-19; idiopathic;
D O I
10.3390/gastroent14040039
中图分类号
R57 [消化系及腹部疾病];
学科分类号
摘要
Background and aim: Over the last few years, SARS-CoV-2 has been reported as a possible cause of acute pancreatitis (AP), but whether it is a relevant clinical-epidemiological entity is still a matter of debate. We aim to evaluate the epidemiological characteristics of AP during the first year of the COVID pandemic (2020) and compare them with the pre-COVID period (2008-2019) to identify any differences and clarify a potential causative role of SARS-CoV-2. Methods: We used a monocentric retrospective study of 132 AP patients during 2020 and 1987 AP patients during 2008-2019. Diagnosis and severity were classified according to the revised Atlanta criteria. Propensity score matching was performed according to clinical-epidemiological features, and outcome analysis was performed on two subgroups of 109 patients. Results: The total number of AP cases in 2020 is one of the lowest in the last 13 years (132 cases, median 161, IQR 146-183). No major epidemiological differences were noted. During 2020, we observed a significant modification of the distribution of etiologies (p < 0.001), mainly based on a decrease in biliary forms (59.6% vs. 43.2%) and an increase in alcoholic forms (6.9% vs. 12.9%). Idiopathic forms remain unchanged (20.5% vs. 21.9%). The proportion of AP of idiopathic etiology and SARS-CoV-2 infection was 0.008%. There were no differences in terms of severity distribution (p = 0.127), length of stay (p = 0.916), need for ICU (p = 0.139), or mortality (p = 0.462). Even among statistically matched groups, there were no differences between the length of stay (9 vs. 10 days, p = 0.890), need for ICU admission (1.8% vs. 3.7%, p = 0.683), or in-hospital mortality (0 vs. 1.8%, p = 0.342). Conclusions: The lower AP diagnoses indicate delayed and likely missed diagnoses, probably because of both hesitancy and organizational problems during the pandemic. The unchanged proportion of idiopathic forms supports the hypothesis that SARS-CoV-2 is not an AP trigger.
引用
收藏
页码:553 / 563
页数:11
相关论文
共 50 条
  • [41] Acute pancreatitis in a patient with COVID-19: A case report
    Kolhe, Manoj
    Sharma, Praveen
    Anikhindi, Shrihari
    Bansal, Naresh
    Saachdeva, Munish
    Arora, Anil
    INTERNATIONAL JOURNAL OF HEPATOBILIARY AND PANCREATIC DISEASES, 2020, 10 (02):
  • [42] Acute Pancreatitis Due to COVID-19 Active Infection
    Annie, Frank H.
    Chumbe, Julton
    Searls, Lauren
    Amos, Jessica
    Campbell, James
    Kemper, Suzanne
    Embrey, Sarah
    Bashir, Muhammad
    CUREUS JOURNAL OF MEDICAL SCIENCE, 2021, 13 (12)
  • [43] Rare presentation of acute pancreatitis in mild COVID-19
    Hatch-Vallier, Brianna
    Jarodiya, Vijay
    Hawa, Fadi
    Daniel, Rebecca
    BMJ CASE REPORTS, 2021, 14 (11)
  • [44] COVID-19 reduced access to dental care
    Paul Hellyer
    British Dental Journal, 2021, 231 : 301 - 301
  • [45] Acute pancreatitis and COVID-19: a new target for infection?
    Balthazar, Julia Aith
    Chehter, Ethel Zimberg
    EINSTEIN-SAO PAULO, 2022, 20 : eRW6667
  • [46] Recurrent Acute Pancreatitis in a Patient with COVID-19 Infection
    Cheung, Szeya
    Fuentes, Alain Delgado
    Fetterman, Alan D.
    AMERICAN JOURNAL OF CASE REPORTS, 2020, 21 : 1 - 3
  • [47] COVID-19 treatment: A potential cause of acute pancreatitis
    Allam, Magdy Mohamed
    El-Zawawy, Hanaa Tarek
    Ahmed, Soha Magdy
    Abdelhamid, Mohamed Aly
    CLINICAL CASE REPORTS, 2022, 10 (10):
  • [48] Review on acute pancreatitis attributed to COVID-19 infection
    Onoyama, Takumi
    Koda, Hiroki
    Hamamoto, Wataru
    Kawahara, Shiho
    Sakamoto, Yuri
    Yamashita, Taro
    Kurumi, Hiroki
    Kawata, Soichiro
    Takeda, Yohei
    Matsumoto, Kazuya
    Isomoto, Hajime
    WORLD JOURNAL OF GASTROENTEROLOGY, 2022, 28 (19) : 2034 - 2056
  • [49] Acute pancreatitis in a patient with COVID-19: A case report
    Kolhe, Manoj
    Sharma, Praveen
    Anikhindi, Shrihari
    Bansal, Naresh
    Saachdeva, Munish
    Arora, Anil
    INTERNATIONAL JOURNAL OF HEPATOBILIARY AND PANCREATIC DISEASES, 2020, 10
  • [50] Surgical intervention for acute pancreatitis in the COVID-19 era
    Su, Yu-Jang
    Chen, Tse-Hao
    WORLD JOURNAL OF CLINICAL CASES, 2022, 10 (31) : 11292 - 11298